title: Adherence with medications used to treat osteoporosis: behavioral insights.
abstract: Non-persistence (never starting or stopping medication prematurely) and non-compliance (taking medication inappropriately) with fracture prevention medication among those at high risk of fracture remain significant barriers to optimal reduction of osteoporotic fractures. Current research suggest that for patients to persist and comply with prescriptions for fracture prevention medication, they need to believe that they are at significant risk of fracture, that the prescribed medication can safely reduce their risk of fracture without exposing them to long-term harm, that equally effective non-medicinal therapies are not available, and that they can successfully execute medication use in the context of their daily task demands. Further research is needed to understand; a) the mental models of osteoporosis, fractures, and medications used to treat osteoporosis that patients employ when making decisions as to whether or not to take fracture prevention medication; and b) how patients arbitrage information from various sources (health care providers, family, friends, and other sources) to formulate their beliefs about osteoporosis and medications used to treat it.
authors: Park Nicollet Osteoporosis Center and Park Nicollet Institute for Research and Education, Park Nicollet Health Services, 3800 Park Nicollet Blvd., Minneapolis, MN 55416, USA. John.Schousboe@ParkNicollet.com
authors: John T
authors: JT
authors: Schousboe
mesh_terms: D001294:Attitude to Health; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015438:Health Behavior; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000453:epidemiology / Q000517:prevention & control*; D010349:Patient Compliance / Q000523:psychology*; D010817:Physician-Patient Relations; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents